Balyasny Asset Management’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $85.3K | Buy |
+10,509
| New | +$85.3K | ﹤0.01% | 1900 |
|
|
2024
Q2 | – | Sell |
-37,367
| Closed | -$198K | – | 2202 |
|
|
2024
Q1 | $198K | Sell |
37,367
-36,813
| -50% | -$195K | ﹤0.01% | 1790 |
|
|
2023
Q4 | $459K | Buy |
+74,180
| New | +$459K | ﹤0.01% | 1457 |
|
|
2023
Q3 | – | Sell |
-13,316
| Closed | -$129K | – | 2012 |
|
|
2023
Q2 | $129K | Sell |
13,316
-4,054
| -23% | -$39.2K | ﹤0.01% | 1706 |
|
|
2023
Q1 | $65.6K | Buy |
+17,370
| New | +$65.6K | ﹤0.01% | 1920 |
|
|
2016
Q2 | – | Sell |
-10,270
| Closed | -$108K | – | 1114 |
|
|
2016
Q1 | $108K | Sell |
10,270
-11,260
| -52% | -$118K | ﹤0.01% | 993 |
|
|
2015
Q4 | $255K | Buy |
21,530
+10,930
| +103% | +$129K | ﹤0.01% | 884 |
|
|
2015
Q3 | $124K | Buy |
+10,600
| New | +$124K | ﹤0.01% | 885 |
|